| Code | Description | Claims | Beneficiaries | Total Paid |
| G0378 |
Hospital observation service, per hour |
8,593 |
8,111 |
$10.32M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
1,662 |
1,528 |
$10.11M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
34,803 |
32,405 |
$8.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
37,456 |
35,389 |
$8.09M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
40,426 |
38,296 |
$7.23M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
10,274 |
10,165 |
$7.09M |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
1,529 |
1,216 |
$6.03M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
37,833 |
33,573 |
$5.88M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
69,961 |
26,879 |
$5.85M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
7,209 |
7,131 |
$5.75M |
| C1889 |
Implantable/insertable device, not otherwise classified |
17,347 |
15,384 |
$5.67M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19,763 |
16,647 |
$4.96M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
21,914 |
18,748 |
$4.61M |
| 93458 |
|
2,403 |
2,378 |
$4.40M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
19,245 |
18,601 |
$3.76M |
| J9271 |
Injection, pembrolizumab, 1 mg |
405 |
296 |
$3.32M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
12,653 |
8,902 |
$2.99M |
| C1874 |
Stent, coated/covered, with delivery system |
1,230 |
1,207 |
$2.76M |
| J2323 |
Injection, natalizumab, 1 mg |
355 |
345 |
$2.55M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,676 |
980 |
$2.53M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13,677 |
10,105 |
$2.51M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
3,107 |
3,084 |
$2.47M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
32,898 |
30,968 |
$2.36M |
| 93454 |
|
1,300 |
1,282 |
$2.22M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
3,484 |
2,940 |
$2.13M |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
1,305 |
1,290 |
$2.11M |
| J2350 |
Injection, ocrelizumab, 1 mg |
67 |
63 |
$2.06M |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
1,112 |
1,022 |
$2.03M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,111 |
7,930 |
$1.93M |
| 80053 |
Comprehensive metabolic panel |
184,723 |
166,433 |
$1.86M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
3,495 |
3,447 |
$1.86M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,965 |
7,726 |
$1.80M |
| 93320 |
|
5,638 |
5,340 |
$1.78M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
84,686 |
84,004 |
$1.70M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,140 |
8,330 |
$1.63M |
| 67311 |
|
748 |
600 |
$1.49M |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
18,593 |
2,368 |
$1.46M |
| 97161 |
|
12,407 |
12,264 |
$1.45M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,002 |
997 |
$1.42M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
10,364 |
10,094 |
$1.39M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,916 |
3,681 |
$1.36M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
56,385 |
54,713 |
$1.34M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
56,460 |
54,772 |
$1.30M |
| 96415 |
|
3,527 |
2,758 |
$1.28M |
| 80050 |
General health panel |
39,135 |
38,855 |
$1.28M |
| C1769 |
Guide wire |
7,173 |
6,256 |
$1.28M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
979 |
829 |
$1.26M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
44,312 |
18,028 |
$1.25M |
| 10E0XZZ |
|
1,461 |
205 |
$1.22M |
| 93975 |
|
2,986 |
2,926 |
$1.20M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
700 |
607 |
$1.15M |
| 80061 |
Lipid panel |
123,064 |
121,978 |
$1.13M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,037 |
3,962 |
$1.12M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
724 |
724 |
$1.12M |
| 86480 |
|
21,166 |
20,987 |
$1.06M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12,069 |
11,464 |
$1.02M |
| 84443 |
Thyroid stimulating hormone (TSH) |
77,576 |
76,162 |
$1.01M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
397 |
291 |
$997K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
27,321 |
24,095 |
$972K |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
173 |
169 |
$955K |
| 95708 |
|
2,442 |
1,508 |
$929K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
247,377 |
217,048 |
$918K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
212 |
134 |
$865K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
812 |
448 |
$861K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
94,086 |
83,450 |
$852K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,632 |
3,135 |
$829K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
645 |
432 |
$811K |
| C1760 |
Closure device, vascular (implantable/insertable) |
2,195 |
1,976 |
$791K |
| 76825 |
|
2,598 |
2,462 |
$746K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
43,484 |
43,155 |
$734K |
| 80076 |
|
54,955 |
50,093 |
$732K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
10,043 |
5,097 |
$728K |
| J3490 |
Unclassified drugs |
57,192 |
36,536 |
$725K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
3,304 |
3,223 |
$712K |
| 86769 |
|
19,035 |
18,321 |
$693K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,792 |
1,071 |
$650K |
| 93017 |
|
7,010 |
6,903 |
$649K |
| 95816 |
|
1,980 |
1,935 |
$629K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,395 |
4,283 |
$625K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
99,717 |
98,620 |
$624K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,036 |
1,984 |
$582K |
| 86900 |
|
21,678 |
19,895 |
$580K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
20,254 |
20,178 |
$569K |
| 82607 |
|
46,734 |
46,370 |
$568K |
| 93970 |
|
2,126 |
2,069 |
$563K |
| 93976 |
|
1,410 |
1,381 |
$528K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
6,179 |
5,862 |
$513K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
21,020 |
20,938 |
$512K |
| 87497 |
|
12,496 |
6,557 |
$487K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,295 |
5,240 |
$485K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,179 |
6,080 |
$484K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,969 |
1,926 |
$475K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25,569 |
24,318 |
$457K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
918 |
795 |
$444K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,948 |
2,317 |
$440K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,609 |
15,748 |
$432K |
| C1766 |
Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
786 |
781 |
$427K |
| 88342 |
|
8,901 |
8,585 |
$425K |
| 88185 |
|
3,442 |
3,312 |
$417K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28,975 |
27,046 |
$410K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,637 |
1,611 |
$399K |
| 86803 |
|
36,404 |
36,058 |
$399K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
21,754 |
20,511 |
$391K |
| 84439 |
|
54,428 |
53,432 |
$390K |
| 42830 |
|
251 |
249 |
$388K |
| 86850 |
|
21,682 |
19,865 |
$387K |
| 76641 |
|
3,966 |
3,533 |
$384K |
| 96450 |
|
642 |
510 |
$377K |
| J0485 |
Injection, belatacept, 1 mg |
238 |
179 |
$374K |
| 29580 |
|
2,157 |
918 |
$366K |
| 94060 |
|
2,466 |
2,397 |
$363K |
| 81507 |
|
794 |
772 |
$354K |
| 83970 |
|
7,675 |
7,434 |
$354K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
259 |
258 |
$344K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,973 |
20,885 |
$336K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13,086 |
12,896 |
$335K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,433 |
8,388 |
$332K |
| 82728 |
|
32,321 |
31,636 |
$329K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,259 |
2,987 |
$320K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,803 |
1,784 |
$318K |
| J0185 |
Injection, aprepitant, 1 mg |
1,047 |
656 |
$314K |
| 96900 |
|
5,925 |
1,176 |
$314K |
| 76770 |
|
1,307 |
1,293 |
$313K |
| 97162 |
|
2,182 |
2,170 |
$312K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,713 |
1,942 |
$298K |
| 95700 |
|
1,812 |
1,789 |
$295K |
| 93325 |
|
8,834 |
8,103 |
$288K |
| C1753 |
Catheter, intravascular ultrasound |
283 |
279 |
$280K |
| 87481 |
|
4,181 |
3,860 |
$278K |
| 88307 |
|
3,099 |
2,966 |
$275K |
| 87536 |
|
3,616 |
3,549 |
$268K |
| 82746 |
|
23,381 |
23,191 |
$264K |
| 86235 |
|
6,053 |
5,816 |
$263K |
| 36430 |
|
909 |
577 |
$262K |
| 97165 |
|
2,907 |
2,870 |
$261K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,193 |
1,166 |
$259K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
826 |
816 |
$249K |
| 86003 |
|
4,724 |
3,644 |
$247K |
| 86901 |
|
21,605 |
19,809 |
$243K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
715 |
527 |
$235K |
| 97116 |
|
2,649 |
1,289 |
$234K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,674 |
1,656 |
$230K |
| 87799 |
|
4,243 |
2,686 |
$228K |
| 87507 |
|
1,206 |
1,187 |
$228K |
| 36415 |
Collection of venous blood by venipuncture |
78,742 |
71,005 |
$223K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,670 |
834 |
$222K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
65 |
49 |
$218K |
| 93880 |
|
1,399 |
1,381 |
$213K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
38,496 |
26,966 |
$213K |
| 31624 |
|
301 |
294 |
$211K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,015 |
1,729 |
$211K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
12,676 |
4,169 |
$210K |
| 77336 |
|
523 |
226 |
$210K |
| J0583 |
Injection, bivalirudin, 1 mg |
1,326 |
1,256 |
$209K |
| 81001 |
|
78,401 |
74,015 |
$209K |
| 83516 |
|
12,096 |
9,692 |
$207K |
| 62323 |
|
316 |
310 |
$207K |
| 83880 |
|
9,379 |
8,994 |
$205K |
| 84403 |
|
8,624 |
8,501 |
$205K |
| 88184 |
|
3,246 |
3,120 |
$204K |
| 11102 |
|
378 |
370 |
$204K |
| 94726 |
|
2,485 |
2,406 |
$202K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
3,324 |
3,125 |
$199K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,412 |
12,493 |
$197K |
| 86780 |
|
20,813 |
20,635 |
$196K |
| 86706 |
|
22,961 |
22,655 |
$195K |
| 87340 |
|
25,865 |
25,455 |
$193K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,884 |
1,078 |
$193K |
| 82803 |
|
14,596 |
13,511 |
$193K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,810 |
1,560 |
$189K |
| 76830 |
Ultrasound, transvaginal |
3,912 |
3,790 |
$188K |
| 10005 |
|
320 |
318 |
$186K |
| 84153 |
|
13,044 |
12,918 |
$183K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
39,213 |
35,059 |
$181K |
| 76536 |
|
1,977 |
1,968 |
$180K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
33,721 |
32,219 |
$180K |
| 85027 |
|
38,361 |
37,414 |
$179K |
| J0897 |
Injection, denosumab, 1 mg |
83 |
77 |
$178K |
| 83655 |
|
13,623 |
13,512 |
$177K |
| 92526 |
|
1,047 |
660 |
$175K |
| 94010 |
|
2,946 |
2,583 |
$172K |
| 88341 |
|
3,505 |
3,280 |
$168K |
| 82784 |
|
14,164 |
12,751 |
$168K |
| 77300 |
|
497 |
419 |
$166K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,625 |
16,149 |
$164K |
| 82670 |
|
6,445 |
6,389 |
$163K |
| 59025 |
Fetal non-stress test |
1,868 |
1,582 |
$163K |
| 87517 |
|
4,052 |
3,667 |
$162K |
| C1781 |
Mesh (implantable) |
216 |
216 |
$160K |
| 71250 |
|
1,496 |
1,482 |
$160K |
| 11900 |
|
463 |
452 |
$157K |
| 87522 |
Neg quan hep c or qual rna |
4,274 |
3,631 |
$156K |
| 83540 |
|
33,849 |
33,323 |
$154K |
| 83550 |
|
27,411 |
26,982 |
$153K |
| J7050 |
Infusion, normal saline solution, 250 cc |
31,107 |
24,445 |
$151K |
| 99201 |
|
1,796 |
1,748 |
$149K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,293 |
1,210 |
$147K |
| 93971 |
|
2,033 |
1,992 |
$145K |
| 80197 |
|
15,456 |
8,664 |
$145K |
| 83001 |
|
8,679 |
8,590 |
$143K |
| 84146 |
|
8,140 |
7,978 |
$142K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
4,932 |
3,419 |
$140K |
| 83735 |
|
42,171 |
30,407 |
$139K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,047 |
1,029 |
$138K |
| 93451 |
|
86 |
67 |
$138K |
| 93304 |
|
543 |
479 |
$137K |
| 77334 |
|
443 |
402 |
$135K |
| 77066 |
Tomosynthesis, mammo |
1,153 |
1,141 |
$133K |
| 86762 |
|
10,597 |
10,520 |
$132K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,290 |
5,232 |
$130K |
| 31575 |
|
453 |
441 |
$130K |
| 86765 |
|
11,482 |
11,395 |
$129K |
| 83520 |
|
5,718 |
5,635 |
$128K |
| 84270 |
|
5,609 |
5,477 |
$128K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,649 |
1,475 |
$127K |
| 12001 |
|
324 |
320 |
$127K |
| 10060 |
|
378 |
366 |
$124K |
| 83002 |
|
7,663 |
7,583 |
$124K |
| C1776 |
Joint device (implantable) |
12 |
12 |
$124K |
| 76000 |
|
2,007 |
1,961 |
$123K |
| 0002A |
|
3,368 |
3,358 |
$123K |
| 95800 |
|
600 |
595 |
$121K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,297 |
2,723 |
$120K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,756 |
1,710 |
$120K |
| 77065 |
Tomosynthesis, mammo |
1,237 |
1,197 |
$117K |
| 83013 |
|
1,854 |
1,842 |
$117K |
| 86787 |
|
11,941 |
11,831 |
$116K |
| 86360 |
|
2,846 |
2,809 |
$116K |
| 86160 |
|
7,842 |
6,215 |
$116K |
| J2327 |
Injection, risankizumab-rzaa, intravenous, 1 mg |
13 |
13 |
$114K |
| 0001A |
|
3,748 |
3,740 |
$113K |
| 84702 |
|
18,904 |
17,403 |
$113K |
| 86140 |
|
32,811 |
31,713 |
$112K |
| 86704 |
|
12,815 |
12,702 |
$112K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
42,876 |
39,043 |
$111K |
| J2704 |
Injection, propofol, 10 mg |
50,955 |
36,963 |
$108K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
2,132 |
2,104 |
$107K |
| 84481 |
|
8,778 |
8,608 |
$104K |
| 87070 |
|
19,254 |
18,014 |
$104K |
| 70496 |
|
482 |
471 |
$100K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
511 |
504 |
$98K |
| 96417 |
|
2,365 |
1,409 |
$96K |
| 93350 |
|
986 |
960 |
$95K |
| 86376 |
|
7,628 |
7,534 |
$94K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,255 |
1,164 |
$94K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,175 |
10,838 |
$94K |
| 76642 |
|
1,217 |
1,182 |
$93K |
| 86735 |
|
8,446 |
8,381 |
$92K |
| 82248 |
|
17,240 |
14,698 |
$92K |
| 86200 |
|
5,899 |
5,877 |
$92K |
| V2632 |
Posterior chamber intraocular lens |
548 |
478 |
$90K |
| 92978 |
|
344 |
337 |
$90K |
| 82627 |
|
4,639 |
4,597 |
$89K |
| 84445 |
|
1,685 |
1,668 |
$89K |
| 76827 |
|
2,591 |
2,460 |
$89K |
| 92610 |
|
618 |
613 |
$89K |
| 77080 |
|
1,667 |
1,631 |
$88K |
| 96367 |
|
1,480 |
1,224 |
$86K |
| 86147 |
|
2,378 |
2,083 |
$84K |
| 82570 |
|
18,547 |
18,006 |
$82K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,893 |
2,864 |
$79K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
25 |
25 |
$78K |
| 93613 |
|
51 |
51 |
$78K |
| 83021 |
|
4,972 |
4,929 |
$78K |
| 84100 |
|
21,085 |
15,374 |
$77K |
| 86800 |
|
6,123 |
5,941 |
$77K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
173 |
171 |
$76K |
| 84480 |
|
8,441 |
8,275 |
$76K |
| 85610 |
|
32,771 |
29,340 |
$75K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
414 |
412 |
$75K |
| 49083 |
|
125 |
67 |
$75K |
| 86334 |
|
3,672 |
3,594 |
$74K |
| 49650 |
|
29 |
29 |
$73K |
| 97166 |
|
502 |
495 |
$73K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,202 |
4,040 |
$72K |
| 82105 |
|
6,929 |
6,449 |
$72K |
| 86225 |
|
8,586 |
8,220 |
$72K |
| 86695 |
|
4,918 |
4,888 |
$71K |
| 71046 |
Radiologic examination, chest; 2 views |
18,869 |
18,035 |
$71K |
| 17110 |
|
133 |
130 |
$71K |
| 58558 |
|
49 |
49 |
$70K |
| 87511 |
|
1,993 |
1,965 |
$70K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,069 |
1,034 |
$69K |
| 86696 |
|
4,944 |
4,887 |
$69K |
| 97802 |
|
1,141 |
1,123 |
$68K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
15 |
12 |
$68K |
| 97803 |
|
1,697 |
1,521 |
$68K |
| 86359 |
|
2,508 |
2,474 |
$67K |
| 82043 |
|
14,618 |
14,494 |
$67K |
| 93798 |
|
857 |
151 |
$67K |
| 82024 |
|
1,821 |
1,770 |
$66K |
| 88112 |
|
1,731 |
1,678 |
$66K |
| 81401 |
|
640 |
624 |
$66K |
| C1731 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes) |
28 |
28 |
$65K |
| 76942 |
|
490 |
468 |
$65K |
| 93925 |
|
762 |
754 |
$65K |
| 0004A |
|
1,758 |
1,755 |
$65K |
| 45381 |
|
130 |
128 |
$64K |
| 87186 |
|
10,458 |
9,739 |
$63K |
| 74230 |
|
477 |
475 |
$63K |
| 85730 |
|
22,427 |
20,996 |
$62K |
| 70486 |
|
894 |
878 |
$61K |
| 86708 |
|
5,995 |
5,955 |
$60K |
| 83615 |
|
16,697 |
13,038 |
$59K |
| 85652 |
|
32,087 |
31,228 |
$59K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,886 |
1,832 |
$59K |
| 86146 |
|
1,953 |
1,781 |
$59K |
| 97035 |
|
2,966 |
1,257 |
$59K |
| 12011 |
|
153 |
149 |
$58K |
| 86038 |
|
7,271 |
7,202 |
$58K |
| J3535 |
Drug administered through a metered dose inhaler |
2,367 |
2,088 |
$58K |
| 96416 |
|
177 |
95 |
$58K |
| 84154 |
|
3,443 |
3,415 |
$55K |
| 81514 |
|
522 |
382 |
$55K |
| 86790 |
|
3,208 |
3,150 |
$55K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
2,266 |
2,266 |
$55K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
5,425 |
2,837 |
$54K |
| 80081 |
|
700 |
700 |
$54K |
| C1759 |
Catheter, intracardiac echocardiography |
14 |
14 |
$54K |
| 82550 |
|
9,108 |
8,843 |
$53K |
| 83883 |
|
2,662 |
2,491 |
$52K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,443 |
1,410 |
$52K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
329 |
319 |
$51K |
| 86592 |
|
17,630 |
17,498 |
$51K |
| 95886 |
|
863 |
843 |
$51K |
| 88360 |
|
800 |
776 |
$50K |
| 74183 |
|
186 |
184 |
$50K |
| 94729 |
|
1,785 |
1,741 |
$50K |
| 82378 |
|
3,932 |
3,499 |
$47K |
| 84425 |
|
2,841 |
2,822 |
$47K |
| 84550 |
|
12,628 |
12,194 |
$47K |
| 87077 |
|
6,406 |
5,692 |
$47K |
| 88304 |
|
2,031 |
2,011 |
$46K |
| 82533 |
|
3,128 |
2,891 |
$46K |
| 96402 |
|
663 |
603 |
$45K |
| 86618 |
|
2,994 |
2,925 |
$44K |
| 67312 |
|
27 |
26 |
$44K |
| 70491 |
|
171 |
167 |
$43K |
| 95911 |
|
244 |
239 |
$43K |
| 86617 |
|
2,615 |
1,745 |
$42K |
| 84402 |
|
1,632 |
1,607 |
$41K |
| 90715 |
|
1,908 |
1,884 |
$40K |
| 84432 |
|
2,306 |
2,218 |
$40K |
| 86665 |
|
2,142 |
1,875 |
$40K |
| 84305 |
|
2,474 |
2,439 |
$39K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,058 |
1,014 |
$39K |
| 82785 |
|
3,312 |
3,265 |
$39K |
| 84436 |
|
9,591 |
9,470 |
$39K |
| 84165 |
|
4,877 |
4,759 |
$39K |
| C1714 |
Catheter, transluminal atherectomy, directional |
287 |
67 |
$38K |
| 83498 |
|
1,512 |
1,505 |
$38K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
17,987 |
16,328 |
$37K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
709 |
669 |
$37K |
| 86923 |
|
1,166 |
976 |
$37K |
| 87631 |
|
922 |
910 |
$36K |
| 86747 |
|
2,322 |
1,361 |
$36K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,273 |
3,137 |
$36K |
| 86357 |
|
1,262 |
1,242 |
$36K |
| 82088 |
|
939 |
877 |
$35K |
| 81003 |
|
27,713 |
26,002 |
$35K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,608 |
10,627 |
$35K |
| 82948 |
|
28,613 |
19,507 |
$34K |
| 88313 |
|
1,159 |
1,114 |
$34K |
| 93623 |
|
41 |
38 |
$34K |
| 86039 |
|
4,515 |
4,489 |
$33K |
| 95953 |
|
101 |
54 |
$33K |
| 86355 |
|
1,143 |
1,127 |
$33K |
| 87493 |
|
1,305 |
1,106 |
$32K |
| 86812 |
|
1,108 |
1,104 |
$32K |
| 88141 |
|
3,039 |
3,022 |
$32K |
| 82652 |
|
942 |
933 |
$31K |
| 76098 |
|
126 |
114 |
$31K |
| 87081 |
|
6,287 |
6,191 |
$31K |
| 86255 |
|
3,174 |
3,108 |
$31K |
| 86021 |
|
2,032 |
1,573 |
$30K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
31,753 |
28,522 |
$30K |
| 77295 |
|
86 |
85 |
$30K |
| 36591 |
|
596 |
444 |
$30K |
| 86694 |
|
1,977 |
1,961 |
$30K |
| 0124A |
|
707 |
707 |
$30K |
| 87660 |
|
1,842 |
1,802 |
$29K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
4,964 |
4,848 |
$28K |
| 86256 |
|
1,118 |
1,077 |
$28K |
| 95812 |
|
100 |
99 |
$28K |
| 84144 |
|
1,405 |
1,334 |
$27K |
| 30140 |
|
13 |
12 |
$27K |
| 83690 |
|
22,301 |
21,039 |
$27K |
| 67314 |
|
48 |
40 |
$27K |
| 86300 |
|
1,663 |
1,504 |
$26K |
| C1729 |
Catheter, drainage |
407 |
272 |
$26K |
| 84703 |
|
24,749 |
23,266 |
$26K |
| 86430 |
|
5,222 |
5,205 |
$26K |
| 86707 |
|
2,642 |
2,616 |
$25K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
24,647 |
19,822 |
$25K |
| 82977 |
|
5,181 |
4,636 |
$25K |
| 77386 |
|
141 |
12 |
$25K |
| 85613 |
|
1,930 |
1,894 |
$24K |
| 72141 |
|
128 |
127 |
$24K |
| 88108 |
|
679 |
522 |
$24K |
| 87510 |
|
1,578 |
1,549 |
$24K |
| 82274 |
|
2,655 |
2,633 |
$24K |
| 87480 |
|
1,541 |
1,513 |
$23K |
| 87350 |
|
2,451 |
2,433 |
$23K |
| 72131 |
|
203 |
202 |
$23K |
| 84207 |
|
879 |
875 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
185 |
184 |
$22K |
| 84484 |
|
19,639 |
15,996 |
$22K |
| 81513 |
|
460 |
459 |
$22K |
| 82164 |
|
1,474 |
1,466 |
$22K |
| 82951 |
|
2,581 |
2,370 |
$22K |
| 84156 |
|
7,587 |
6,820 |
$22K |
| 86664 |
|
1,896 |
1,865 |
$22K |
| 83695 |
|
1,652 |
1,642 |
$22K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
564 |
550 |
$22K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
3,711 |
2,324 |
$22K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
164 |
89 |
$21K |
| 81243 |
|
657 |
635 |
$21K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
24,139 |
21,503 |
$21K |
| 82085 |
|
1,546 |
1,511 |
$21K |
| 64644 |
|
49 |
49 |
$21K |
| 84681 |
|
1,138 |
1,130 |
$20K |
| 87512 |
|
502 |
490 |
$20K |
| 87329 |
|
2,046 |
1,743 |
$20K |
| 73562 |
|
1,573 |
1,380 |
$19K |
| 86663 |
|
1,943 |
1,912 |
$19K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,384 |
1,345 |
$19K |
| 85240 |
|
1,499 |
1,487 |
$19K |
| 82985 |
|
1,565 |
1,545 |
$19K |
| 83921 |
|
1,020 |
1,010 |
$19K |
| 88312 |
|
901 |
869 |
$19K |
| 86141 |
|
1,794 |
1,775 |
$19K |
| 95913 |
|
100 |
100 |
$19K |
| 84244 |
|
835 |
817 |
$19K |
| 83993 |
|
1,317 |
1,305 |
$18K |
| 96401 |
|
269 |
114 |
$18K |
| 86777 |
|
1,412 |
1,400 |
$18K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
19,376 |
18,696 |
$18K |
| 86778 |
|
1,411 |
1,399 |
$18K |
| 64642 |
|
26 |
26 |
$18K |
| 73564 |
|
1,610 |
1,442 |
$17K |
| 87177 |
|
2,137 |
1,825 |
$17K |
| 87338 |
|
1,813 |
1,795 |
$17K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,275 |
1,089 |
$17K |
| 73630 |
|
2,461 |
2,287 |
$17K |
| 0054A |
|
440 |
432 |
$17K |
| 86304 |
|
1,464 |
1,346 |
$17K |
| 77002 |
|
72 |
68 |
$17K |
| 82397 |
|
1,536 |
1,517 |
$16K |
| 83010 |
|
1,769 |
1,719 |
$16K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
75 |
66 |
$16K |
| 82157 |
|
615 |
612 |
$16K |
| 87147 |
|
3,546 |
3,454 |
$16K |
| 86335 |
|
496 |
484 |
$16K |
| J1815 |
Injection, insulin, per 5 units |
3,341 |
1,957 |
$16K |
| 81329 |
|
172 |
162 |
$16K |
| 93656 |
|
14 |
14 |
$16K |
| 87205 |
|
6,412 |
5,972 |
$16K |
| 90677 |
|
78 |
75 |
$15K |
| 80069 |
|
1,986 |
1,718 |
$15K |
| 85379 |
|
5,868 |
5,669 |
$15K |
| 86431 |
|
3,161 |
3,143 |
$15K |
| 86644 |
|
1,267 |
1,248 |
$15K |
| 87045 |
|
2,068 |
1,406 |
$15K |
| 96411 |
|
283 |
163 |
$14K |
| 80074 |
|
386 |
382 |
$14K |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
24 |
24 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
902 |
786 |
$14K |
| 83525 |
|
1,387 |
1,355 |
$14K |
| 86645 |
|
1,399 |
1,353 |
$14K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,195 |
1,824 |
$14K |
| 88142 |
|
768 |
766 |
$14K |
| 73030 |
|
1,845 |
1,735 |
$14K |
| 73130 |
|
1,995 |
1,825 |
$14K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,362 |
2,271 |
$14K |
| 82150 |
|
3,002 |
2,787 |
$13K |
| 0003A |
|
365 |
365 |
$13K |
| 80177 |
|
1,516 |
1,476 |
$13K |
| 86709 |
|
1,599 |
1,583 |
$13K |
| 93308 |
|
69 |
65 |
$13K |
| 82610 |
|
899 |
874 |
$13K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,264 |
3,259 |
$13K |
| L8699 |
Prosthetic implant, not otherwise specified |
12 |
12 |
$13K |
| 88262 |
|
151 |
149 |
$12K |
| 71045 |
Radiologic examination, chest; single view |
5,854 |
5,538 |
$12K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
34 |
12 |
$12K |
| 83721 |
|
3,288 |
3,252 |
$12K |
| 86885 |
|
124 |
124 |
$12K |
| 72156 |
|
72 |
68 |
$12K |
| 90686 |
|
972 |
953 |
$12K |
| 86317 |
|
219 |
212 |
$12K |
| 83521 |
|
97 |
96 |
$12K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
115 |
70 |
$12K |
| 87102 |
|
2,054 |
1,957 |
$12K |
| 87209 |
|
1,075 |
914 |
$12K |
| 76870 |
|
609 |
593 |
$12K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,276 |
2,234 |
$12K |
| 72100 |
|
669 |
655 |
$11K |
| 87328 |
|
1,060 |
901 |
$11K |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,134 |
6,271 |
$11K |
| 84460 |
|
2,873 |
2,676 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27,452 |
24,595 |
$11K |
| 86364 |
|
430 |
417 |
$11K |
| 84479 |
|
2,817 |
2,792 |
$11K |
| 82950 |
|
2,495 |
2,487 |
$11K |
| 93505 |
|
24 |
14 |
$10K |
| 82668 |
|
708 |
700 |
$10K |
| 81376 |
|
216 |
209 |
$10K |
| 85045 |
|
4,641 |
4,322 |
$10K |
| 54161 |
|
12 |
12 |
$10K |
| 87116 |
|
1,626 |
1,388 |
$10K |
| 80164 |
|
955 |
905 |
$10K |
| 64493 |
|
15 |
12 |
$10K |
| 78306 |
|
47 |
41 |
$10K |
| 81383 |
|
176 |
174 |
$10K |
| 82103 |
|
849 |
830 |
$10K |
| 82390 |
|
1,154 |
1,144 |
$10K |
| 83835 |
|
600 |
573 |
$10K |
| 86301 |
|
816 |
733 |
$9K |
| 74174 |
|
111 |
109 |
$9K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,058 |
1,028 |
$9K |
| 73110 |
|
1,395 |
1,258 |
$9K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
382 |
380 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
48 |
44 |
$9K |
| J9190 |
Injection, fluorouracil, 500 mg |
212 |
116 |
$9K |
| 64643 |
|
85 |
39 |
$9K |
| 87272 |
|
827 |
706 |
$9K |
| 70498 |
|
301 |
300 |
$9K |
| 73610 |
|
1,979 |
1,869 |
$8K |
| 83951 |
|
148 |
125 |
$8K |
| 73502 |
|
1,030 |
964 |
$8K |
| 93312 |
|
169 |
156 |
$8K |
| 86671 |
|
438 |
435 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
435 |
422 |
$8K |
| 87106 |
|
840 |
835 |
$8K |
| 87075 |
|
1,449 |
1,317 |
$8K |
| 90662 |
|
191 |
191 |
$8K |
| 93321 |
|
816 |
726 |
$8K |
| 80175 |
|
776 |
761 |
$8K |
| 84075 |
|
1,998 |
1,817 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,023 |
4,588 |
$8K |
| 84466 |
|
790 |
780 |
$7K |
| 84630 |
|
847 |
842 |
$7K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,515 |
1,241 |
$7K |
| G0008 |
Administration of influenza virus vaccine |
399 |
393 |
$7K |
| 87632 |
|
160 |
156 |
$7K |
| 86705 |
|
802 |
797 |
$7K |
| 84446 |
|
617 |
615 |
$7K |
| 83090 |
|
459 |
459 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
670 |
647 |
$7K |
| 85670 |
|
1,734 |
1,701 |
$7K |
| 86682 |
|
680 |
672 |
$7K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
54 |
53 |
$7K |
| 86341 |
|
382 |
362 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,725 |
3,251 |
$7K |
| 80305 |
|
2,622 |
2,258 |
$7K |
| 87653 |
|
263 |
262 |
$7K |
| 82310 |
|
1,948 |
1,778 |
$7K |
| 95076 |
|
14 |
12 |
$7K |
| 75574 |
|
53 |
53 |
$7K |
| 88237 |
|
77 |
75 |
$7K |
| 84590 |
|
702 |
699 |
$7K |
| 94760 |
|
1,983 |
1,810 |
$7K |
| 82172 |
|
402 |
400 |
$7K |
| 84450 |
|
2,408 |
2,228 |
$7K |
| J9045 |
Injection, carboplatin, 50 mg |
124 |
67 |
$6K |
| 85306 |
|
500 |
493 |
$6K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,712 |
2,614 |
$6K |
| 86870 |
|
70 |
69 |
$6K |
| 82247 |
|
2,412 |
2,177 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,514 |
3,742 |
$6K |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
361 |
340 |
$6K |
| 84155 |
|
2,863 |
2,682 |
$6K |
| 82565 |
|
1,976 |
1,896 |
$6K |
| 85732 |
|
1,135 |
1,119 |
$6K |
| 76826 |
|
43 |
37 |
$6K |
| 88172 |
|
309 |
282 |
$6K |
| 78451 |
|
14 |
14 |
$6K |
| 80299 |
|
389 |
381 |
$6K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,774 |
2,716 |
$6K |
| 38222 |
|
13 |
13 |
$5K |
| 87899 |
|
758 |
728 |
$5K |
| 82955 |
|
569 |
568 |
$5K |
| 20553 |
|
26 |
25 |
$5K |
| S0028 |
Injection, famotidine, 20 mg |
6,025 |
4,706 |
$5K |
| 87040 |
|
4,792 |
3,109 |
$5K |
| 82140 |
|
303 |
275 |
$5K |
| 85384 |
|
1,218 |
1,081 |
$5K |
| 87634 |
|
183 |
180 |
$5K |
| 82232 |
|
382 |
372 |
$5K |
| 96376 |
|
3,041 |
2,693 |
$5K |
| 86666 |
|
408 |
405 |
$5K |
| 82787 |
|
209 |
208 |
$5K |
| 78264 |
|
24 |
24 |
$5K |
| 81450 |
|
113 |
111 |
$5K |
| 82040 |
|
1,853 |
1,741 |
$5K |
| C1758 |
Catheter, ureteral |
415 |
405 |
$5K |
| 82947 |
|
1,781 |
1,710 |
$4K |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
207 |
199 |
$4K |
| 87150 |
|
163 |
158 |
$4K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,396 |
2,218 |
$4K |
| 82465 |
|
1,701 |
1,670 |
$4K |
| J9267 |
Injection, paclitaxel, 1 mg |
89 |
36 |
$4K |
| 73700 |
|
17 |
17 |
$4K |
| 82107 |
|
79 |
77 |
$4K |
| 93225 |
|
48 |
48 |
$4K |
| 88173 |
|
425 |
394 |
$4K |
| 87625 |
|
263 |
263 |
$4K |
| 88189 |
|
131 |
129 |
$4K |
| 87206 |
|
1,469 |
1,199 |
$4K |
| 82525 |
|
371 |
369 |
$4K |
| 88280 |
|
254 |
249 |
$4K |
| J2720 |
Injection, protamine sulfate, per 10 mg |
595 |
592 |
$4K |
| 95819 |
|
12 |
12 |
$4K |
| 89051 |
|
2,055 |
1,831 |
$4K |
| 80195 |
|
550 |
375 |
$4K |
| 85303 |
|
340 |
336 |
$4K |
| 87563 |
|
141 |
140 |
$4K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,599 |
4,321 |
$4K |
| 73080 |
|
937 |
901 |
$4K |
| 72170 |
|
764 |
748 |
$4K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
413 |
391 |
$4K |
| 87430 |
|
1,321 |
1,310 |
$4K |
| 72158 |
|
27 |
25 |
$4K |
| 87046 |
|
643 |
614 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
140 |
134 |
$3K |
| 85300 |
|
371 |
369 |
$3K |
| 87640 |
|
166 |
162 |
$3K |
| 86015 |
|
33 |
22 |
$3K |
| 29125 |
|
12 |
12 |
$3K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,486 |
1,246 |
$3K |
| 0134A |
|
76 |
76 |
$3K |
| 73590 |
|
1,177 |
1,104 |
$3K |
| 85097 |
|
51 |
50 |
$3K |
| 36416 |
|
222 |
218 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,886 |
1,314 |
$3K |
| 86361 |
|
848 |
844 |
$3K |
| 84166 |
|
216 |
214 |
$3K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
624 |
561 |
$3K |
| 81241 |
|
234 |
233 |
$3K |
| 84145 |
|
1,021 |
983 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
579 |
470 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,322 |
1,720 |
$3K |
| 86945 |
|
242 |
116 |
$3K |
| 96116 |
|
13 |
12 |
$3K |
| 86757 |
|
93 |
93 |
$3K |
| 73140 |
|
387 |
372 |
$3K |
| 84134 |
|
288 |
281 |
$3K |
| 86738 |
|
114 |
111 |
$3K |
| J3360 |
Injection, diazepam, up to 5 mg |
517 |
480 |
$3K |
| 85246 |
|
140 |
137 |
$3K |
| 73090 |
|
765 |
729 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
69 |
68 |
$3K |
| 83718 |
|
644 |
642 |
$3K |
| 87341 |
|
286 |
279 |
$3K |
| 90670 |
|
13 |
12 |
$3K |
| 70544 |
|
24 |
24 |
$3K |
| J0280 |
Injection, aminophyllin, up to 250 mg |
355 |
339 |
$3K |
| 76377 |
|
93 |
93 |
$2K |
| 84132 |
|
1,083 |
1,012 |
$2K |
| 85347 |
|
3,027 |
2,099 |
$2K |
| 85576 |
|
56 |
51 |
$2K |
| 82374 |
|
1,048 |
979 |
$2K |
| 93226 |
|
48 |
48 |
$2K |
| 84295 |
|
1,021 |
952 |
$2K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
3,014 |
2,548 |
$2K |
| 81240 |
|
209 |
207 |
$2K |
| 0031A |
|
74 |
74 |
$2K |
| 87581 |
|
219 |
211 |
$2K |
| 86352 |
|
31 |
26 |
$2K |
| 82435 |
|
1,022 |
953 |
$2K |
| 74018 |
|
648 |
619 |
$2K |
| 72157 |
|
15 |
13 |
$2K |
| 84255 |
|
76 |
76 |
$2K |
| 87486 |
|
198 |
193 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
283 |
243 |
$2K |
| J2305 |
Injection, nitroglycerin, 5 mg |
600 |
594 |
$2K |
| 84520 |
|
1,038 |
969 |
$2K |
| 96368 |
|
294 |
181 |
$2K |
| 95714 |
|
34 |
26 |
$2K |
| 86593 |
|
663 |
654 |
$2K |
| 87210 |
|
964 |
908 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
408 |
316 |
$2K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
13 |
13 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,166 |
859 |
$2K |
| 82657 |
|
96 |
94 |
$2K |
| 87529 |
|
39 |
38 |
$2K |
| 86258 |
|
29 |
16 |
$2K |
| 90656 |
|
147 |
146 |
$2K |
| 0072A |
|
50 |
50 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
577 |
394 |
$2K |
| 84478 |
|
609 |
606 |
$2K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,048 |
581 |
$2K |
| 85307 |
|
125 |
125 |
$2K |
| 88271 |
|
40 |
40 |
$2K |
| 95874 |
|
160 |
159 |
$2K |
| 0071A |
|
69 |
69 |
$2K |
| 81206 |
|
24 |
24 |
$2K |
| 93923 |
|
12 |
12 |
$1K |
| 88275 |
|
28 |
28 |
$1K |
| 81002 |
|
544 |
539 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
86 |
86 |
$1K |
| 84238 |
|
31 |
30 |
$1K |
| 87449 |
|
182 |
178 |
$1K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
293 |
288 |
$1K |
| 84080 |
|
115 |
110 |
$1K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
12 |
12 |
$1K |
| 86215 |
|
97 |
93 |
$1K |
| 0051A |
|
28 |
28 |
$1K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
93 |
38 |
$1K |
| 88331 |
|
53 |
52 |
$1K |
| 88387 |
|
181 |
162 |
$1K |
| J9250 |
Methotrexate sodium, 5 mg |
635 |
436 |
$1K |
| 76885 |
|
12 |
12 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
221 |
217 |
$1K |
| 95887 |
|
26 |
25 |
$1K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
891 |
890 |
$1K |
| J3411 |
Injection, thiamine hcl, 100 mg |
804 |
680 |
$1K |
| 82552 |
|
745 |
667 |
$980.61 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
289 |
184 |
$940.26 |
| 87255 |
|
38 |
38 |
$887.04 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
77 |
65 |
$873.87 |
| 76828 |
|
43 |
37 |
$869.66 |
| J3489 |
Injection, zoledronic acid, 1 mg |
12 |
12 |
$840.16 |
| 86692 |
|
54 |
54 |
$833.91 |
| 83014 |
|
107 |
106 |
$831.10 |
| 83519 |
|
43 |
41 |
$800.69 |
| 83605 |
|
577 |
545 |
$800.10 |
| 96132 |
|
13 |
12 |
$797.52 |
| 88365 |
|
12 |
12 |
$796.36 |
| 86231 |
|
26 |
26 |
$758.76 |
| 97014 |
|
12 |
12 |
$734.95 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
129 |
121 |
$732.37 |
| 88311 |
|
159 |
158 |
$720.48 |
| 87185 |
|
166 |
157 |
$715.79 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
80 |
79 |
$713.13 |
| 82009 |
|
296 |
271 |
$702.33 |
| 73552 |
|
218 |
208 |
$675.70 |
| 85245 |
|
38 |
38 |
$666.66 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
2,995 |
2,343 |
$657.63 |
| 80183 |
|
62 |
62 |
$635.03 |
| 86063 |
|
121 |
116 |
$623.20 |
| 94618 |
|
24 |
24 |
$614.64 |
| 82945 |
|
151 |
140 |
$611.83 |
| 80178 |
|
115 |
110 |
$603.21 |
| 86880 |
|
41 |
41 |
$581.52 |
| 86325 |
|
26 |
26 |
$575.21 |
| 81270 |
|
27 |
26 |
$569.70 |
| 97010 |
|
57 |
16 |
$550.19 |
| 88177 |
|
12 |
12 |
$548.97 |
| 80320 |
|
1,115 |
1,005 |
$542.90 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
89 |
86 |
$533.73 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
29 |
29 |
$528.67 |
| 82330 |
|
68 |
68 |
$527.74 |
| 91300 |
|
7,909 |
7,040 |
$523.33 |
| 88285 |
|
26 |
25 |
$516.92 |
| 80321 |
|
17 |
13 |
$509.29 |
| 84157 |
|
188 |
175 |
$480.84 |
| 82595 |
|
86 |
84 |
$475.79 |
| 0053A |
|
12 |
12 |
$471.87 |
| 86340 |
|
41 |
40 |
$466.97 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,193 |
1,182 |
$459.84 |
| 80349 |
|
188 |
178 |
$439.20 |
| 72128 |
|
12 |
12 |
$426.23 |
| 80348 |
|
185 |
156 |
$424.20 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
648 |
627 |
$387.62 |
| 87521 |
Neg quan hep c or qual rna |
12 |
12 |
$378.96 |
| 81015 |
|
1,216 |
1,151 |
$354.52 |
| 87275 |
|
98 |
98 |
$350.47 |
| 81291 |
|
13 |
13 |
$334.54 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
114 |
104 |
$331.75 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
111 |
88 |
$329.22 |
| 0107U |
|
60 |
59 |
$323.20 |
| 76376 |
|
104 |
104 |
$319.38 |
| 86308 |
|
95 |
95 |
$309.45 |
| 87324 |
|
31 |
29 |
$304.65 |
| J2060 |
Injection, lorazepam, 2 mg |
615 |
512 |
$300.79 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
50 |
50 |
$296.52 |
| 85018 |
|
140 |
140 |
$295.63 |
| J1940 |
Injection, furosemide, up to 20 mg |
253 |
195 |
$289.37 |
| 73560 |
|
16 |
16 |
$282.60 |
| 82010 |
|
460 |
429 |
$280.04 |
| 82340 |
|
57 |
56 |
$274.45 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
13 |
13 |
$260.04 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
108 |
107 |
$251.72 |
| J1630 |
Injection, haloperidol, up to 5 mg |
360 |
296 |
$249.65 |
| 82530 |
|
15 |
13 |
$249.63 |
| 80230 |
|
14 |
14 |
$241.07 |
| 85014 |
|
139 |
139 |
$239.07 |
| 77062 |
|
18 |
15 |
$232.48 |
| 85247 |
|
12 |
12 |
$230.60 |
| J1836 |
Injection, metronidazole, 10 mg |
284 |
213 |
$216.39 |
| 73010 |
|
38 |
37 |
$212.00 |
| 73060 |
|
152 |
148 |
$203.86 |
| 82542 |
|
12 |
12 |
$195.76 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
44 |
44 |
$192.10 |
| G0009 |
Administration of pneumococcal vaccine |
14 |
14 |
$187.69 |
| J1921 |
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg |
15 |
13 |
$187.62 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
4,038 |
3,300 |
$173.51 |
| 81050 |
|
53 |
53 |
$162.00 |
| 80329 |
|
66 |
65 |
$158.66 |
| 91312 |
|
512 |
512 |
$157.50 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
13 |
$152.31 |
| 82270 |
|
75 |
75 |
$139.78 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
1,443 |
1,294 |
$139.40 |
| 82365 |
|
13 |
13 |
$133.00 |
| 82104 |
|
13 |
13 |
$122.09 |
| 90749 |
|
13 |
12 |
$116.55 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
120 |
120 |
$114.11 |
| 85660 |
|
33 |
33 |
$106.32 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
33 |
29 |
$105.16 |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
179 |
91 |
$103.57 |
| 96523 |
|
48 |
40 |
$102.82 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,333 |
2,329 |
$95.74 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
306 |
278 |
$88.51 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
150 |
150 |
$76.43 |
| 91305 |
|
262 |
255 |
$74.41 |
| 94728 |
|
20 |
13 |
$68.42 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
27 |
27 |
$53.49 |
| J7999 |
Compounded drug, not otherwise classified |
1,228 |
1,186 |
$46.88 |
| 80346 |
|
27 |
25 |
$44.60 |
| 87184 |
|
13 |
13 |
$43.27 |
| 88300 |
|
38 |
38 |
$38.41 |
| 87541 |
|
116 |
112 |
$35.09 |
| J1953 |
Injection, levetiracetam, 10 mg |
12 |
12 |
$33.87 |
| 91307 |
|
114 |
111 |
$33.64 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
16 |
14 |
$32.70 |
| J1597 |
Injection, glycopyrrolate (glyrx-pf), 0.1 mg |
159 |
134 |
$27.73 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
64 |
52 |
$26.02 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
112 |
75 |
$9.88 |
| 91313 |
|
32 |
32 |
$9.61 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
23 |
19 |
$8.54 |
| Q9954 |
Oral magnetic resonance contrast agent, per 100 ml |
15 |
15 |
$2.70 |
| 91303 |
|
72 |
72 |
$2.00 |
| J7517 |
Mycophenolate mofetil, oral, 250 mg |
31 |
14 |
$1.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
24 |
24 |
$1.00 |
| G0124 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
429 |
429 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
150 |
149 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
143 |
143 |
$0.00 |
| 76857 |
|
24 |
24 |
$0.00 |
| 99080 |
|
550 |
94 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
17 |
17 |
$0.00 |
| C8937 |
Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) |
12 |
12 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
12 |
12 |
$0.00 |
| 64494 |
|
15 |
12 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
12 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
31 |
30 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
28 |
27 |
$0.00 |
| 67320 |
|
12 |
12 |
$0.00 |